Search

Preston C Conrad

from Carmel, IN
Age ~71
Get Report
Also known as:
Preston Evelyn Conrad, Pete C Conrad
Phone and address:
12987 Grenville St, Carmel, IN 46032
(317) 564-8694
Related to:
Evelyn Wetzel Conrad, 70Erika ConradE F ConradStefanie A Gudis, 42Erika F Martini, 42Anthony J Martini, 44Paul T Conrad, 41
Connected to:
Alta C Conrad, 104Amy M Conrad, 50Angelina Conrad, 101Ashtyn B Conrad, 34Becca A Conrad, 27Bozena Conrad, 62Bret C Conrad, 50Brigitte Conrad, 41Brittiany Conrad, 35Carl E Conrad, 73

Preston Conrad Phones & Addresses

  • 12987 Grenville St, Carmel, IN 46032 (317) 564-8694
  • 1400 Priscilla Ct, West Lafayette, IN 47906 (765) 464-0932
  • 1702 Ashbury Ct, West Lafayette, IN 47906 (765) 464-0932
  • 7336 Campfire Run, Indianapolis, IN 46236 (317) 823-8776
  • 911 Gaffield Pl, Evanston, IL 60201 (847) 733-8582
  • 2731 Hampden Ct, Chicago, IL 60614 (773) 857-0620
  • W Lafayette, IN
  • 911 Gaffield Pl, Evanston, IL 60201

Work

Company: Eurofins alphora, alphora research inc Jul 2016 Position: Scientific advisor

Education

School / High School: University of Wisconsin - Madison 1979 to 1981 Specialities: Organic Chemistry

Skills

Pharmaceutical Industry • Technology Transfer • Chemistry • Drug Development • Gmp • Hplc • Biotechnology • Drug Discovery • R&D • Validation • Analytical Chemistry • Regulatory Submissions • Organic Chemistry • Chromatography • Clinical Research • Glp • Oncology • Clinical Trials • Lifesciences

Industries

Pharmaceuticals

Resumes

Resumes

Preston Conrad Photo 1

Scientific Advisor

View page
Location:
12987 Grenville St, Carmel, IN 46032
Industry:
Pharmaceuticals
Work:
Eurofins Alphora, Alphora Research Inc
Scientific Advisor
Eli Lilly and Company Oct 1981 - Mar 2016
Research Advisor at Eli Lilly and Company
Education:
University of Wisconsin - Madison 1979 - 1981
Purdue University 1975 - 1979
Doctorates, Doctor of Philosophy, Philosophy, Organic Chemistry
Skills:
Pharmaceutical Industry
Technology Transfer
Chemistry
Drug Development
Gmp
Hplc
Biotechnology
Drug Discovery
R&D
Validation
Analytical Chemistry
Regulatory Submissions
Organic Chemistry
Chromatography
Clinical Research
Glp
Oncology
Clinical Trials
Lifesciences

Publications

Us Patents

Crystalline Form Of 6-Hydroxy-3-(4-[2-(Piperidin-1-Yl)Ethoxy]Phenoxy)-2-(4-Methoxyphenyl)Benzo[B]Thiophene Hydrochloride

View page
US Patent:
6610706, Aug 26, 2003
Filed:
Jan 10, 2002
Appl. No.:
10/031324
Inventors:
Julie Kay Bush - Fishers IN
Preston Charles Conrad - Indianapolis IN
Merlyn Gerard Flom - Noblesville IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31445
US Classification:
514324, 546202
Abstract:
The present invention is directed to a novel crystalline hydrate of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]-phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride and uses for same, including inhibition of disease states associated with estrogen deprivation including cardiovascular disease, hyperlipidemia, and osteoporosis; and inhibition of other pathological conditions such as endometriosis, uterine fibrosis, estrogen-dependent cancer (including breast and uterine cancer), prostate cancer, benign prostatic hyperplasia, CNS disorders including Alzheimers disease, prevention of breast cancer, and up-regulating ChAT.

Crystalline Form Of 6-Hydroxy-3-(4-[2-(Piperidin-1-Yl)Ethoxy]Phenoxy)-2-(4-Methoxyphenyl)Benzo[B] Thiophene Hydrochloride

View page
US Patent:
6653479, Nov 25, 2003
Filed:
Jan 10, 2002
Appl. No.:
10/031326
Inventors:
Julie Kay Bush - Fishers IN
Preston Charles Conrad - Indianapolis IN
Merlyn Gerard Flom - Noblesville IN
Wayne Douglas Luke - West Lafayette IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D40900
US Classification:
546202, 548525
Abstract:
The present invention is directed to a novel crystalline hydrate of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride and uses for same, including inhibition of disease states associated with estrogen deprivation including cardiovascular disease, hyperlipidemia, and osteoporosis; and inhibition of other pathological conditions such as endometriosis, uterine fibrosis, estrogen-dependent cancer (including breast and uterine cancer), prostate cancer, benign prostatic hyperplasia, CNS disorders including Alzheimers disease, prevention of breast cancer, and up-regulating ChAT.

Process For Preparing 2-Phenyl-3-Aminobenzothiophenes

View page
US Patent:
20040044224, Mar 4, 2004
Filed:
Sep 2, 2003
Appl. No.:
10/344246
Inventors:
Preston Conrad - West Lafayette IN, US
John Gardner - Indianapolis IN, US
International Classification:
C07D333/72
US Classification:
549/006000, 549/055000
Abstract:
The present invention relates to a one pot process for preparing a compound of formula I: I; from a compound of formula II and III: I; III.

Crystalline 7-(R)-Amino-3-(1'Pyridiniummethyl)-Ceph-3-Em-4-Carboxylate Monohydrochloride Monohydrate Compound

View page
US Patent:
45407797, Sep 10, 1985
Filed:
Jun 20, 1983
Appl. No.:
6/505662
Inventors:
Preston C. Conrad - Indianapolis IN
Alvydas A. Jarmas - Speedway IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D50138
A61K 3144
US Classification:
544 24
Abstract:
Crystalline 7-(R)-amino-3-(1'-pyridiniummethyl)-ceph-3-em-4-carboxylate monohydrochloride monohydrate compound is an intermediate in the synthesis of the cephalosporin antibiotic ceftazidime.
Control profile
Preston C Conrad from Carmel, IN, age ~71 Get Report